GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (BSP:AMGN34) » Definitions » Shiller PE Ratio

Amgen (BSP:AMGN34) Shiller PE Ratio : 27.77 (As of May. 11, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Amgen Shiller PE Ratio?

As of today (2024-05-11), Amgen's current share price is R$57.48. Amgen's E10 for the quarter that ended in Mar. 2024 was R$2.07. Amgen's Shiller PE Ratio for today is 27.77.

The historical rank and industry rank for Amgen's Shiller PE Ratio or its related term are showing as below:

BSP:AMGN34' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.58   Med: 26.86   Max: 36.6
Current: 26.55

During the past years, Amgen's highest Shiller PE Ratio was 36.60. The lowest was 18.58. And the median was 26.86.

BSP:AMGN34's Shiller PE Ratio is ranked worse than
52.45% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs BSP:AMGN34: 26.55

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Amgen's adjusted earnings per share data for the three months ended in Mar. 2024 was R$-0.037. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is R$2.07 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amgen Shiller PE Ratio Historical Data

The historical data trend for Amgen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amgen Shiller PE Ratio Chart

Amgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.03 26.12 22.55 23.60 24.23

Amgen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.84 18.86 22.47 24.23 24.33

Competitive Comparison of Amgen's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Amgen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amgen's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amgen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amgen's Shiller PE Ratio falls into.



Amgen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amgen's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=57.48/2.07
=27.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amgen's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Amgen's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.037/129.4194*129.4194
=-0.037

Current CPI (Mar. 2024) = 129.4194.

Amgen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.161 100.560 0.207
201409 0.134 100.428 0.173
201412 0.159 99.070 0.208
201503 0.237 99.621 0.308
201506 0.239 100.684 0.307
201509 0.340 100.392 0.438
201512 0.328 99.792 0.425
201603 0.330 100.470 0.425
201606 0.302 101.688 0.384
201609 0.311 101.861 0.395
201612 0.310 101.863 0.394
201703 0.312 102.862 0.393
201706 0.342 103.349 0.428
201709 0.309 104.136 0.384
201712 -0.693 104.011 -0.862
201803 0.381 105.290 0.468
201806 0.469 106.317 0.571
201809 0.420 106.507 0.510
201812 0.417 105.998 0.509
201903 0.436 107.251 0.526
201906 0.492 108.070 0.589
201909 0.481 108.329 0.575
201912 0.418 108.420 0.499
202003 0.536 108.902 0.637
202006 0.565 108.767 0.672
202009 0.661 109.815 0.779
202012 0.507 109.897 0.597
202103 0.570 111.754 0.660
202106 0.145 114.631 0.164
202109 0.624 115.734 0.698
202112 0.679 117.630 0.747
202203 0.476 121.301 0.508
202206 0.442 125.017 0.458
202209 0.745 125.227 0.770
202212 0.562 125.222 0.581
202303 0.982 127.348 0.998
202306 0.446 128.729 0.448
202309 0.568 129.860 0.566
202312 0.248 129.419 0.248
202403 -0.037 129.419 -0.037

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amgen  (BSP:AMGN34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amgen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amgen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amgen (BSP:AMGN34) Business Description

Address
One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen (BSP:AMGN34) Headlines

No Headlines